TY  - GEN
AU  - Heo,Yong-Seok
AU  - Heo,Yong-Seok
TI  - Recent Advances in Antibody Therapeutics
SN  - books978-3-0365-4354-3
PY  - 2022///
CY  - Basel
PB  - MDPI - Multidisciplinary Digital Publishing Institute
KW  - Research & information: general
KW  - bicssc
KW  - Chemistry
KW  - interleukin 33
KW  - ST2 receptor
KW  - scFv
KW  - C2_2E12
KW  - bladder cancer
KW  - antibodies
KW  - immune checkpoint inhibitors
KW  - antibody-drug conjugates
KW  - sacituzumab govitecan
KW  - enfortumab vedotin
KW  - erdafitinib
KW  - cost-effectiveness
KW  - G protein-coupled receptor
KW  - membrane protein
KW  - antigen
KW  - therapeutic antibody
KW  - anti-angiogenesis
KW  - delta-like ligand
KW  - irinotecan
KW  - paclitaxel
KW  - VEGF
KW  - SARS-CoV-2
KW  - spike protein
KW  - receptor-binding domain
KW  - phage display
KW  - monoclonal antibody
KW  - cytomegalovirus
KW  - peptide/major histocompatibility complex class I complex
KW  - T-cell-receptor-like antibody
KW  - affinity maturation
KW  - yeast surface display
KW  - combinatorial antibody library
KW  - agonist antibody
KW  - cell fate
KW  - bispecific antibodies
KW  - bioassays
KW  - mechanisms of action
KW  - binding assays
KW  - potency assays
KW  - atherosclerosis
KW  - inflammation
KW  - antibody therapy
KW  - blood-brain barrier
KW  - antibody
KW  - pharmacokinetics
KW  - disposition
KW  - biochemical and physicochemical properties
KW  - Fc binding
KW  - receptor-mediated transcytosis
KW  - brain shuttle
KW  - molecular Trojan horse
KW  - transferrin
KW  - anti-cancer antibody
KW  - antibody engineering
KW  - biophysical properties
KW  - computational methods
KW  - research cell bank
KW  - antibody therapeutics
KW  - recombinant antibodies
KW  - intracellular antibodies
KW  - single-chain antibody fragment
KW  - nanobody
KW  - Human papillomaviruses
KW  - HPV oncoproteins
KW  - HPV-associated cancer
KW  - HPV cancer therapy
KW  - asthma
KW  - refractory asthma
KW  - biomarker
KW  - n/a
N1  - Open Access
N2  - Since first receiving approval in 1986, antibody-based therapeutics have been the most successful modality for the treatment of various diseases. This Special Issue of IJMS, "Recent Advances in Antibody Therapeutics", presents leading-edge articles and reviews for discovery, development, and clinical applications of therapeutic antibodies, covering antibody drug conjugates (ADCs), GPCR-targeting antibodies, a functional antibody screening, bioassay of bispecific antibodies, antibody applications for cardiovascular diseases, antibody delivery to CNS, etc. The excellent studies in this Special Issue would valuable insight for scientists and clinicians in the field of therapeutic antibodies
UR  - https://mdpi.com/books/pdfview/book/5595
UR  - https://directory.doabooks.org/handle/20.500.12854/87408
ER  -